DEBORAH ANDERSON: Open Payments
NPI 1538698030 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,096 in 93 payments from 29 companies in 2025. Trend: 2023 $1,464 · 2024 $1,473 · 2025 $2,096
Food & beverage: $1,996Education: $100
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 10 | $235 |
| Merck Sharp & Dohme LLC | 7 | $226 |
| Janssen Biotech, Inc. | 10 | $205 |
| PharmaEssentia USA Corporation | 6 | $130 |
| AstraZeneca Pharmaceuticals LP | 5 | $116 |
| Incyte Corporation | 6 | $109 |
| Gilead Sciences, Inc. | 3 | $102 |
| SEAGEN INC. | 1 | $100 |
| Eisai Inc. | 4 | $92 |
| Karyopharm Therapeutics Inc. | 4 | $86 |
Products named: REBLOZYL, KEYTRUDA, BESREMI, OPDIVO, Trodelvy, Lenvima, RYBREVANT, XPOVIO.
Industry payments across SC — which companies pay providers there.
